Request Deal Involvement
Bristol Myers Squibb completed the acquisition of Mirati Therapeutics for $4.7bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Centerview Partners
legal advisors to financial advisors
Paul Weiss Rifkind Wharton & Garrison
pr advisors
FGS Global
legal advisors
Wolf Theiss
legal advisors
Arnold & Porter Kaye Scholer
financial advisors
Ropes & Gray
financial advisors
Morgan Stanley
financial advisors
Evercore
legal advisors
Kirkland & Ellis
pr advisors
Joele Frank
legal advisors to financial advisors
Sullivan & Cromwell
or
Principals
target
MIRATI THERAPEUTICS
bidder
BRISTOL MYERS SQUIBB COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite